BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21885653)

  • 1. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
    Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
    FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations.
    Wang L; Muthu P; Szczesna-Cordary D; Kawai M
    J Muscle Res Cell Motil; 2013 May; 34(2):93-105. PubMed ID: 23397074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the N-terminus of the myosin essential light chain in cardiac muscle contraction.
    Kazmierczak K; Xu Y; Jones M; Guzman G; Hernandez OM; Kerrick WG; Szczesna-Cordary D
    J Mol Biol; 2009 Apr; 387(3):706-25. PubMed ID: 19361417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
    Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
    Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca(2+) sensitivity and cross-bridge detachment kinetics.
    Michael JJ; Gollapudi SK; Ford SJ; Kazmierczak K; Szczesna-Cordary D; Chandra M
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H253-9. PubMed ID: 23144314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
    Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.
    Kazmierczak K; Yuan CC; Liang J; Huang W; Rojas AI; Szczesna-Cordary D
    Front Physiol; 2014; 5():353. PubMed ID: 25295008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin essential light chain in health and disease.
    Hernandez OM; Jones M; Guzman G; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1643-54. PubMed ID: 17142342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
    Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
    FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin.
    Mettikolla P; Calander N; Luchowski R; Gryczynski I; Gryczynski Z; Zhao J; Szczesna-Cordary D; Borejdo J
    J Theor Biol; 2011 Sep; 284(1):71-81. PubMed ID: 21723297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.
    Gomes AV; Kazmierczak K; Cheah JX; Gilda JE; Yuan CC; Zhou Z; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):447-61. PubMed ID: 26668058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
    Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
    FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.
    Huang W; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.